Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Unknown status Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20041
20111
20151
20172
20181
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Andarix Pharmaceuticals1
Carisma Therapeutics Inc1
Chipscreen Biosciences, Ltd.1
Garden State Cancer Center at the Center for Molecular Medicine and Immunology1
Herbert Irving Comprehensive Cancer Center1
Jewish Hospital and St. Mary's Healthcare1
LUNGevity Foundation1
Merrimack Pharmaceuticals1
MultiVir, Inc.1
South Florida Veterans Affairs Foundation for Research and Education1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma15
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms7
Stomach Neoplasms6
Carcinoma, Transitional Cell4
Neoplasms4
Carcinoma, Squamous Cell3
Anus Neoplasms2
Bile Duct Neoplasms2
Breast Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.